The American Society of Clinical Oncology first published evidence-based practice guidelines for the use of bisphosphonates in breast cancer in 2000 and updated them in 2003. To reflect the proven ...
March 2, 2011 — An updated guideline on the use of bone-modifying agents in patients with metastatic breast cancer have been issued by the American Society of Clinical Oncology (ASCO). The guideline ...
Starting bisphosphonates in women who demonstrate bone destruction through imaging but who have normal plain radiographs is considered reasonable treatment. Starting bisphosphonates in women with only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback